Hui-Feng Gao
Overview
Explore the profile of Hui-Feng Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang K, Li Y, Peng L, Gao H, Liu L, Chen H
Biol Direct
. 2023 Jan;
18(1):1.
PMID: 36631876
Background: Pancreatic cancer (PC) is a highly lethal malignancy that requires effective novel therapies. M2 macrophages are abundant in the PC microenvironment and promote cancer progression. Exosomes are emerging mediators...
2.
Zhang K, Xu P, Li Y, Dong S, Gao H, Chen L, et al.
BMC Genom Data
. 2022 Jan;
23(1):5.
PMID: 35012444
Background: Pancreatic cancer (PC) is a highly lethal disease and an increasing cause of cancer-associated mortality worldwide. Interferon regulatory factors (IRFs) play vital roles in immune response and tumor cellular...
3.
Zhang K, Dong S, Jing Y, Gao H, Chen L, Hua Y, et al.
BMC Cancer
. 2020 Jun;
20(1):541.
PMID: 32517802
Background: Recent evidence suggests that albumin-to-Alkaline Phosphatase Ratio (AAPR) functions as a novel prognostic marker in several malignancies. However, whether it can predict the prognosis of unresectable pancreatic ductal adenocarcinoma...
4.
Gao H, Cheng C, Tang J, Li Y, Chen H, Meng Z, et al.
Aging (Albany NY)
. 2020 Jan;
12(1):502-517.
PMID: 31913856
Chemokines play essential roles in the progression of various human cancers; however, the expression and role of CXC chemokines in pancreatic adenocarcinoma (PAAD) have not yet been identified. The aim...
5.
Gao H, Chen L, Cheng C, Chen H, Meng Z, Chen Z
Cancer Manag Res
. 2019 May;
11:3171-3185.
PMID: 31114359
Accumulating studies have reported that aberrant expression of SLC5A1 is a negative prognostic factor to various cancer patients. Pancreatic cancer tissue has also shown to harbor higher expression of SLC5A1,...
6.
Gao H, Wang Q, Zhang K, Chen L, Cheng C, Chen H, et al.
Biochem Biophys Res Commun
. 2019 Feb;
511(2):482-489.
PMID: 30808544
Pancreatic cancer is a highly malignant tumor of the digestive system. Previous studies have shown that abnormal cell surface glycosylation is associated with cancer metastasis, which suggests that glycosylation changes...
7.
Zhang K, Gao H, Mo M, Wu C, Hua Y, Chen Z, et al.
Pancreatology
. 2019 Jan;
19(2):346-351.
PMID: 30638854
Objective: The aim of this study was to evaluate the prognostic value of pre-treatment plasma hemostatic parameters in patients with advanced pancreatic cancer. Methods: A total of 320 patients diagnosed...
8.
Shi C, Wen X, Gao H, Liu Z, Xu X, Li L, et al.
J Ethnopharmacol
. 2016 Mar;
183:143-150.
PMID: 26934449
Ethnopharmacological Relevance: Intestinal mucositis induced by chemotherapy is a severe clinical problem in cancer patients that currently lack effective interventions. In traditional Chinese medicine, chemotherapeutic toxicity is diagnosed as Qi...
9.
Chen Q, Cheng C, Chen H, Ning Z, Tang S, Zhang X, et al.
PLoS One
. 2014 Aug;
9(8):e101536.
PMID: 25170868
Background: Hepatocellular carcinoma (HCC) can be diagnosed by noninvasive approaches with serum α-fetoprotein (AFP) levels >200 ng/ml and/or a radiological imaging study of tumor mass >2 cm in patients with...
10.
Xie J, Li P, Gao H, Qian J, Yuan L, Wang J
BMC Gastroenterol
. 2014 Apr;
14:70.
PMID: 24712400
Background: Current literature has demonstrated that host glutamine depletion facilitates tumorigenesis. Likewise, the glutamine transporter SLC38A1 is putatively associated with malignant transformation and tumor progression. Taken together, this forms the...